The Australian carrier agreed to pay to settle a class action over its decision not to offer immediate cash refunds for ...
DuckerFrontier's head of research, Martina Bozadzhieva, and practice leader for global economics and scenarios, Ryan Connelly ...
The stock was down 14% premarket after BioNTech announced the departures and issued revenue guidance that fell short of Wall Street’s forecasts.
Six years later, March still carries a hint of menace.
The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...
The Continent green-lights Moderna’s combo flu and Covid shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results